Hepatocellular Carcinoma: Symptoms, Causes, and Treatment Options

If you have been living with hepatitis or cirrhosis for years, you may already know that liver check-ups can turn up something unexpected. Hepatocellular carcinoma is the most common type of primary liver cancer. It often develops in people with long-term liver disease. And here is what surprises many patients: care is guided not only by the tumor itself, but also by how well the liver is functioning.

Overview: What hepatocellular carcinoma is

Hepatocellular carcinoma is the most common form of primary liver cancer, meaning it begins in the liver rather than spreading there from another part of the body. It develops from the main liver cells, called hepatocytes. In many cases, it appears in people who already have chronic liver disease, especially cirrhosis.

With this cancer, your doctor is really watching two things at once: the tumor and the liver it is growing in. Treatment decisions depend on the size, number, and location of tumors — and just as much on whether the liver can still do its normal work well enough to tolerate treatment.

Some cancers announce themselves early. This one can stay silent for a long time, which is why it is often picked up during routine surveillance in people known to be at risk. Found early, more treatment options may be available, including therapies intended to remove or destroy the tumor completely.

Symptoms and how it may present

Early hepatocellular carcinoma may not cause noticeable symptoms. As the disease progresses, symptoms can overlap with those of chronic liver disease, which sometimes makes the condition harder to recognize without imaging or lab tests.

Possible symptoms and signs may include:

• Unexplained weight loss
• Loss of appetite or feeling full quickly
• Pain or discomfort in the upper right abdomen
• Abdominal swelling or bloating
• Fatigue and weakness
• Nausea
• Yellowing of the skin or eyes (jaundice)
• Itching
• Worsening swelling in the legs or abdomen in people with cirrhosis

Some people first come to medical attention because a longstanding liver condition seems to worsen. For example, new fluid buildup in the abdomen, increasing jaundice, or confusion related to liver dysfunction may prompt urgent assessment. In other cases, a liver mass is discovered during surveillance ultrasound or a scan performed for another reason.

These symptoms do not always mean cancer is present, but they should be evaluated by a qualified clinician, especially in someone with known liver disease, hepatitis B, hepatitis C, or a history of heavy alcohol use.

Causes and risk factors

Hepatocellular carcinoma most often develops after years of liver inflammation and scarring. Cirrhosis is the single most important risk factor, but not everyone with cirrhosis will develop liver cancer. Likewise, hepatocellular carcinoma can sometimes occur even before cirrhosis is advanced, especially in chronic hepatitis B.

The main risk factors include chronic hepatitis B infection, chronic hepatitis C infection, alcohol-related liver disease, and metabolic dysfunction-associated steatotic liver disease, which includes liver damage linked to obesity, insulin resistance, and type 2 diabetes. Certain inherited conditions, such as hemochromatosis, can also increase risk.

Additional factors may contribute, including exposure to aflatoxins in some regions, smoking, and longstanding liver inflammation from multiple causes. People with liver cancer risk factors are often advised to have regular follow-up, because early detection can change treatment possibilities significantly.

In many patients, this cancer is the end result of years of repeated liver injury. Treating the cause of that injury — antiviral treatment for hepatitis, or cutting back on alcohol — can lower future risk and support overall liver health at the same time.

How hepatocellular carcinoma is diagnosed

Diagnosis usually begins with a medical history, physical examination, and blood tests that assess liver function. Doctors often check alpha-fetoprotein (AFP), a blood marker that may be elevated in some patients, although it is not accurate enough to diagnose or exclude hepatocellular carcinoma on its own.

Imaging plays a central role. Ultrasound may detect a suspicious lesion, but contrast-enhanced CT or MRI is usually needed to characterize it more clearly. In many patients with cirrhosis or chronic hepatitis B, a typical pattern seen on high-quality imaging can strongly suggest hepatocellular carcinoma without the need for biopsy.

When imaging is not definitive, a biopsy may be recommended to examine tissue under a microscope. Doctors also evaluate how well the liver is working, because this affects both prognosis and treatment planning. The final assessment often includes tumor burden, liver reserve, and the person’s overall health and performance status.

Some people are diagnosed through surveillance programs. Patients at higher risk may have regular liver ultrasound, sometimes with AFP testing, to look for cancer before symptoms appear. This approach is especially relevant for people with cirrhosis and selected patients with chronic hepatitis B.

Treatment options and how care is planned

Treatment for hepatocellular carcinoma is individualized. Doctors consider the stage of the cancer, whether there is one tumor or several, whether blood vessels are involved, whether the cancer has spread, and how well the liver is functioning. This is why care is often planned by a multidisciplinary team that may include hepatologists, oncologists, surgeons, interventional radiologists, transplant specialists, and radiation specialists.

When the tumor is small and the rest of the liver is healthy enough, surgery to remove part of the liver may be an option. In selected patients with early-stage disease and significant cirrhosis, liver transplantation may treat both the cancer and the underlying liver disease. Local therapies can also play a major role. These may include radiofrequency ablation for small tumors or chemoembolization to target tumors through their blood supply.

For some patients, external radiation techniques may be used, and for more advanced disease, systemic therapy may be recommended. This can include targeted medicines or immunotherapy, depending on the clinical situation. The goals may be curative in early stages or focused on controlling disease, relieving symptoms, and preserving quality of life in later stages.

You may also need treatment for complications of liver disease, such as ascites, variceal bleeding risk, or encephalopathy. Supportive care matters at every stage. If you are looking for an evaluation abroad, you can also be assessed at Acıbadem Health Point, where multidisciplinary specialists in JCI-accredited hospitals diagnose and treat complex liver conditions.

Prevention, surveillance, and self-care

Prevention of hepatocellular carcinoma largely focuses on protecting the liver. Vaccination against hepatitis B, treatment of chronic viral hepatitis, limiting alcohol, and addressing obesity, diabetes, and metabolic risk factors can all reduce long-term liver injury. People with known liver disease should ask their doctor whether regular surveillance is appropriate for them.

Surveillance is not the same as prevention, but it is just as much a part of care. In higher-risk groups, routine ultrasound at scheduled intervals can catch suspicious changes earlier, when more treatment options may be available. If you have cirrhosis, keep to your follow-up schedule even on the days you feel perfectly well.

Self-care also matters after diagnosis. Maintaining nutrition, avoiding alcohol unless a doctor specifically advises otherwise, taking medicines as prescribed, and attending all imaging and blood test appointments can help support both liver function and treatment planning. Because the liver processes many drugs and supplements, patients should speak with a clinician before using over-the-counter products or herbal remedies.

Do not overlook the emotional side. A diagnosis of liver cancer brings a lot of uncertainty, especially when chronic liver disease is already part of your life. Talking openly with your care team, leaning on family, and reaching out to counseling or support groups can make treatment decisions and follow-up easier to carry.

When to seek medical care

Medical review is appropriate if a person develops unexplained weight loss, ongoing upper abdominal pain, loss of appetite, new abdominal swelling, jaundice, or persistent fatigue—particularly if there is a history of hepatitis, cirrhosis, alcohol-related liver disease, or fatty liver disease. Even mild new symptoms can be worth discussing because early hepatocellular carcinoma may be subtle.

People already enrolled in liver surveillance should seek medical advice promptly if a scheduled ultrasound, CT, MRI, or blood test shows an abnormal result. Keeping follow-up appointments is essential, since timely confirmation of a suspicious lesion can influence the range of available treatments.

Urgent medical attention is needed for severe confusion, vomiting blood, black stools, marked jaundice, severe abdominal swelling, or sudden worsening weakness. These symptoms may reflect serious liver-related complications and should not be managed at home.

Frequently asked questions